chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient took himself to the observation room; since he felt dizzy after the shot. He fainted and fell to the floor. He hit the left-side of his forehead and cheek, which caused an abrasion. BP 142/90.  He was monitored for 1½ hours until he left with a friend, and was given instructions to watch for head injury symptoms. He walked without assistance. BP 112/90; P87; O2 at 96%.
pt recv vax & 24hr post vax exp a rash on neck which was smooth & not itchy;it spread to back & then to arms & fingers;rash cam & went;ER or MD visit was required;MD stated that the rash was tinea versicolor;poss d/t yeast allergy;
Patient states had some pain during injection which was different from his experience with receiving other vaccines in the past. Left arm/shoulder pain intensified several hours after vaccine was given and caused a sleepless night and inability to move arm as of time of report @ 1330 on 8/15/19. Denies redness, swelling, lumps, or rash in or around the injection site. States injection site was about 3-4 inches below edge of shoulder. Pain radiates from shoulder to wrist with inability to move arm. Measures taken to ease discomfort include use of aspiring and supplements for muscle pain. Patient plans to seek medical attention if symptoms do not resolve in the next 24 hours.
This case was reported by a consumer via call center representative and described the occurrence of pain in a 53-year-old female patient who received SHINGRIX for prophylaxis. On 20th November 2018, the patient received the 1st dose of SHINGRIX (intramuscular). On 20th November 2018, less than a day after receiving SHINGRIX, the patient experienced pain. On 21st November 2018, the patient experienced tiredness. On 22nd November 2018, the patient experienced localized erythema and local swelling. On 23rd November 2018, the outcome of the pain was recovered/resolved. On 24th November 2018, the outcome of the localized erythema and local swelling were recovered/resolved. On an unknown date, the outcome of the tiredness was recovered/resolved. It was unknown if the reporter considered the pain, tiredness, localized erythema and local swelling to be related to SHINGRIX. Additional details were provided as follows: The patient had soreness that lasted for 3 days after the vaccination. One day after the vaccination, the patient had significant tiredness that lasted about 36 hours. Two days after the vaccination, the patient noticed redness and swelling above the injection site about 2.5 inches in diameter. The redness and swelling resolved 4 days after the vaccination. There was a consent for follow up.
This patient complained of rash (approximately 10 lesions) which developed a blister which scabbed over.
Patient son returned 9/8/17 to report 3 days after administration patient went to primary care Dr. for possible reaction. Patient was told to wait to see if resolved. Son states today patient admitted to hospital with severe infection and unable to move arms/neck.
Chills; headache; joint pains; muscle and body aches; fatigue/extremely weak (had to be helped to sit up); nausea; slight fever (~99.8 F); racing heart rate (93, normal resting for me is ~60); heavy breathing, though no difficulty breathing.
Administered expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine) in a 50-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine). On 29-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Administered expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported. No treatment information was provided.  Reporter stated that the vaccines were stored in freezer and they took out one to two vials and placed in fridge each day as needed.
got sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (got sore arm) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (got sore arm). At the time of the report, PAIN IN EXTREMITY (got sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
Subsequent to receiving one dose of rubella virus vaccine live (second generation) the  pt experienced severe burning of her elbows and fingers, her veins hurt all over, she experienced aching joints and "prickles and tingles". The pt noted the experiences are slowly going away. The pt sought unspecified medical treatment. Follow up information indicated that 2 weeks post vax "the blood started burning real bad in my arms. My organs felt like they were shutting down. There was also tingling in my hands". In approximately June, 2000 the pt began to experience pain under her left and right rib cage and she noted that the ache is getting more intense, "like there is no room there".  Additionally, the pt noted that she started getting "lightening bolt pain in the spleen area" and there is aching in her elbows and the fatty part of her palms. The pt also noted "blood came out of both eyes". The pt has been nursing her baby and her physician informed her that the baby has a high white blood cell count and has blood in the urine. Additional information has been requested.
?Covid arm? large, hot, itchy,  tender, swelling at injection site. Appeared 8 days after shot.
Pt c/o pain after vaccination, swelling, redness, tingling and radiating pain traveling down arm to hand. Pt saw neurology - R/O'd nerve involvement. DX: by provider as prob muscle tear vs. hematoma with nerve pressure.
This spontaneous report was received from a registered nurse refers to two patients of unknown age and gender. Concurrent conditions and medical history were not provided. On 16-FEB-2015, two patients were vaccinated with two expired doses of PNEUMOVAX 23 "25/0.5" injection, lot # J005071 and expiration date 19-JAN-2015 (dose and route of administration were not provided). No adverse effect was reported. The concomitant medication was not provided. This is one of two reports received from the same reporter. Additional information has been requested.
tested positive after the first dose; tested positive after the first dose; This is a spontaneous report from a contactable consumer via Pfizer-sponsored program. (Patient, Husband). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Batch/Lot number: Not reported), via an unspecified route of administration on 18Mar2021 as dose 1, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The reporter reported on behalf of her husband, the patient who was tested positive to COVID-19 after the first dose on an unspecified date with outcome of unknown. On an unspecified date the patient underwent lab tests and procedures which included sars-cov-2 test: positive. The reporter stated that the second dose was on 08Apr2021. She was asking as well what to bring for the second dose. The outcome of the events were unknown.  Follow up (10Apr2021): This follow up contains no new medically significant information.  No follow-up attempts are possible; information about lot/batch number cannot been obtained
24 hr after shot lower legs swollen and ankles swollen and painful as of today day 2 after immunization legs still swollen and will follow up with pcp if no improvement by Friday.
Pt with full body hives. No wheezing or difficulty breathing. Given topical steroid cream, loratadine & BENADRYL for itch. Has f/u in 1 wk.
This spontaneous report was received from a medical assistant referring to an unspecified number of patients (age and gender unknown). No information regarding the patients' concurrent conditions, medical history, drug reactions or allergies, and concomitant therapies was provided. The reporter stated that, on unspecified dates, the patients were vaccinated with improperly stored doses of GARDASIL 9 (formulation, strength, dose, frequency, route of administration, anatomical location, lot # and expiration date were not reported) for prophylaxis. The vaccine doses were exposed to an unspecified temperature excursion for an unspecified time; a digital data logger was involved. No adverse effects were reported. There was not product quality complain (PQC) reported. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1705USA012266: US-009507513-1705USA012267: US-009507513-1705USA012268: US-009507513-1705USA012269.
I felt sick to my stomach and couldn't get off the couch; had a headache and felt "off" for about a week and a half. Lost appetite. Had similar reaction to 1st shot but only for an hour or two.
Rash on inside of elbows, worse on arm with injection but no rash at injection site. Not itchy, went away overnight with Benadryl taken before bed.
This spontaneous report was received from a registered nurse, referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 06-APR-2016 the patient was vaccinated with an improperly dose of GARDASIL 9 lot # L011846 with expiration date on 16-JUN-2017, (strength, dose, frequency, route and anatomical location were not reported). No adverse effect was reported and no product quality complaint was involved. Temperature/Time frame: 50.5 Fahrenheit degrees for 1 hour. Back in range? Yes. No prior excursions. Call was because of a data logger. Additional information has been requested.
Faintness , Weakness, Loss of Balance Ability. No answers from any physicians as to the probable cause. Constant feeling that does not change. Health was fine before the vaccine. Never been tested for COVID.  Looking for answers as to how long this might last.
This spontaneous report as received from a physician refers to a 2 month old male patient. The patient had no relevant medical history and past drug history was unknown. On an unknown date the patient was vaccinated with ROTATEQ (orally; dosage, frequency and lot number were not provided). The patient did not use any concomitant medication. On an unknown date in November 2013 the patient experienced respiratory issues and went to the hospital. IT was unknown if the patient was hospitalized. On 09-NOV-2013 the patient was vaccinated with a possibly second dose in the series of ROTATEQ (orally; dosage, frequency and lot number were not provided). The expiration date of this dose was October 2013. The patient was fine after the expired dose was given. On an unknown date in November 2013 the patient recovered from respiratory issues. The relatedness was not provided. Additional information has been requested.
Information has been received from a licensed practical nurse concerning a 5 month old patient who was vaccinated with a dose of pneumococcal vaccine 23 polyvalent (lot number 637261/1067K). Subsequently, the patient's face became red and blotchy after about five minutes. It was reported that the patient's skin erythema faded quickly. Unspecified medical attention was sought. Additional information has been requested.
I started having chills before bed 12 hours after receiving vaccine. I woke up late morning (now 24 hours later)with a terrible migraine and continued to have chills. I went to the bathroom after I woke up and felt very nauseated and sick. I then started seeing black dots and felt very dizzy. Soon after my vision went completely black for what seemed to be about 5 min. I was shaking, having difficulty breathing and fell to the ground. My fiancé called 911 and an ambulance was on its way. The EMTs showed up and took my vitals. At this point I was able to see again and was sitting down. My blood sugar was normal along with my oxygen stats. My blood pressure was low while sitting and standing.  I was starting to feel better and didn?t end up going to the hospital. I continue to have chills, body aches and a headache but so far no more blackening out episodes. It was the scariest experience  of my life!
DERMATITIS:  BLISTERS IN PUBIC AREA, SADDLE, BUTTOX, VAGINA AND UPPER LEG.  SELF ADMINISTERED:  ANTI-FUNGAL LOTION, NEOSPORIN, AND CALAMINE LOTION.
This spontaneous report was received from a medical assistant concerning unspecified number of patients of unknown age and gender. Medical history and concurrent conditions were not reported. On 16-OCT-2014, the patients were vaccinated with improperly stored RECOMBIVAX HB, 0.5 ml, intramuscular. Co-suspect or concomitant therapies were not reported. No adverse effects reported. This is one of several reports from the same source. Additional information has been requested.
negative antibody detection against SARS COV-2 spike protein; received the vaccine first dose on December 30 2020 and the second dose on February 20th 2021/got administered with Pfizers COVID-19 vaccine at the same time he got it; received the vaccine first dose on December 30th 2020 and the second dose on February 20th 2021/got administered with Pfizers COVID-19 vaccine at the same time he got it; This is a spontaneous report from a contactable physician (reported for himself). A 62-years-old male patient received bnt162b2 (BNT162B2, Pfizer-BioNTech Covid-19 Vaccine), dose 2 via an unspecified route of administration on 20Feb2021 (Batch/Lot number and Expiry date was not reported) as single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient received the vaccine first dose on December 30th 2020 and the second dose on February 20th 2021/got administered with Pfizers COVID-19 vaccine, none antibodies developed as expected and negative laboratory results for antibody detection against SARS COV-2 spike protein (vaccination failure and SARS COV-2 antibody test negative), received the vaccine first dose on december 30th 2020 and the second dose on february 20th 2021/got administered with pfizer covid-19 vaccine at the same time he got it (off label use and inappropriate schedule of product administration), physician called requesting information regarding appropriateness of administering to himself a booster dose of Pfizer's COVID-19 vaccine considering his negative laboratory results for antibody detection against SARS COV-2 spike protein. Physician reported that he and his colleague, another health professional, who got administered with Pfizer's COVID-19 vaccine at the same time. The patient underwent lab tests and procedures which included antibody test: negative results for antibody detection against SARS COV-2 spike protein, blood test: rapid blood one, physician reported that results throwed 3 when the expected for a positive result of immune response is 10. Physician reported he has no concomitant conditions that limit his immune response. The outcome of the events was unknown.  Follow-up activities have been completed and information on Lot/Batch number has been requested.; Sender's Comments: Linked Report(s) : -PFIZER INC-2021326452 same drug/AE, different patient
01/07/22 presents to  ED for "fatigue, generalized weakness". PMHx of "L kidney transplant, DM, CAD s/p stent"
Info has been received from a health professional concerning a 9 year old white male with no known history who on 10/30/97 was vaccinated with a 2nd dose of varicella virus vaccine live. There was no concomitant medication. On 12/13/05, the pt developed red lesions over his body and a low-grade temp. On 12/14/05, some lesions were scabbing over and new lesions were appearing. On 12/16/05, no new lesions were developing, he was afebrile and it was reported that one of his classmates was dx'd with chickenpox. Additional info has been requested.
This spontaneous report as received from a physician via an unspecified reporter, refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 24-APR-2014, the patient was vaccinated with a dose of improperly stored PNEUMOVAX 23 "10 Single dose 0.5mLVls 10SDV" and lot number J011998 with expiration date of 12-FEB-2015 (route of administration was unknown), which was stored at -6.66 Celsius Degrees for 552 hours. The type of excursion was refrigerator and the vaccine status in excursion. No concomitant therapies nor adverse effect were reported. No product quality complaint was involved. This is one of several cases from the same reporter. Additional information has been requested.
Patient brought in to visit list of vaccines that were required for his process. One of the vaccines was Hib. Dr. ordered the vaccine and nurse proceeded with administration. After the administration it was found that patient did not meet criteria according to CDC to receive the vaccine. Patient did not present any allergic reaction to the vaccine and he was informed he received a vaccine he did not need.
Pt developed hives on legs, arms, stomach and feet approximately 1 hr post vax.
Painful; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Flu unspecified (Flu vaccine) for prophylaxis.   On an unknown date, the patient received Flu vaccine. On an unknown date, an unknown time after receiving Flu vaccine, the patient experienced pain (Verbatim: Painful). The outcome of the pain was not reported.   It was unknown if the reporter considered the pain to be related to Flu vaccine.     It was unknown if the company considered the pain to be related to Flu vaccine.   Linked case(s) involving the same patient:  US2023AMR050629   Additional Information: GSK Receipt Date: 16-MAR-2023 This case was reported by the patient via interactive digital media. The patient reported that he or she received flu shot and it was painful. This case had been linked with US2023AMR050629 by same reporter for same patient.  Follow-up would not possible as no contact details were available.; Sender's Comments:  US-GSK-US2023AMR050629:same reporter
Myalgia, NauseaVomiting, fatigue, chills Narrative:
administered dose to adult patient from pediatric vials of Moderna COVID-19 Vaccine instead of bivalent booster; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (administered dose to adult patient from pediatric vials of Moderna COVID-19 Vaccine instead of bivalent booster) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (administered dose to adult patient from pediatric vials of Moderna COVID-19 Vaccine instead of bivalent booster) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (administered dose to adult patient from pediatric vials of Moderna COVID-19 Vaccine instead of bivalent booster) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (administered dose to adult patient from pediatric vials of Moderna COVID-19 Vaccine instead of bivalent booster).    No concomitant drug was reported. Reporter stated that on 8-Oct-2022, 9-Oct-2022 and 10-Oct-2022 they administered 26 doses to adult patients. Reporter was not aware of any AEs after the vaccines were given. Lot number and expiration date was unknown for suspect drug. No treatment drug was reported. This case contains information for the 17th of 26 adult patients described by the reporter.
Pt felt swelling on the right side of her neck(has went down) felt soar head hurt when turning but also going away, a little on left side very slight, brain fog on Friday night still very slight, and fatigued (still occurring), headache on first night no longer occurring
Very sore arm at injection site. Chills and low grade fever started evening of day of shot. By night time the day of vaccine, had extreme stomach pain and nausea. Waves of nausea and some stomach pain day following. Arm still sore. Two days after vaccine, arm still sore and stomach still uncomfortable. Still have periods of nausea.
Complained of dizziness, nausea and vomited clear stomach content x1.  Pale complexion.  911 activated.  Vital signs: P 85, BP 116/68, pulse ox 99%.  Released by medics.  Ambulatory, gait steady.  Per mother no allergies or medical history.
Patient states on the evening of receiving vaccine, patient broke out in hives around area of the injection. The following day, patient reported having a "big red water balloon" on the medial side of her upper right arm with pain and without fever.  Patient states she was seen by a provider but was not prescribed medication and was told to monitor for fever. Patient states a few days later, she had stomach pain and cramps with the pain and aches extending to thighs. Patients states after 6 days, symptoms resolved completely.
pt noticed after rcvg 2nd dose she had pain in her gluteus maximus and had pain in her upper left arm.  These symptoms lasted 22 hours. Pt stated feeling feverish.  Fever was 99.1 that rose to 99.7 by night time.  On 2/5/2021 pt had trouble focusing and couldn't read like she had the flu.  Pt had went to a appt to establish care w/ her new PCP and let them know she had been vaccinated but did not give her any medical advice. Pt states she is still having pain in her left thumb which started hurting after 1st covid vax.
Information has been received from a nurse practitioner concerning a Caucasian 49 year old female patient with hypertension and no known drug allergies who on 6/11/03 at 10:30 was vaccinated SC with a 0.5ml first dose of varicella virus vaccine live (lot # 644250/1153M). It was noted that there was no illness at the time of vaccination. Concomitant therapy included betaxolol HCl and hydrochlorothiazide. On 6/28/03 the patient developed 13 lesions and she also complained of cold like symptoms. It was noted at the time of the report she was recovering, and she had a total of 16 lesions which are starting to heal. Follow up information indicated that on 7/3/03, the patient had several more pox appear, but did not feel unwell. It was noted that the patient recovered on 7/7/03. Unspecified medical attention was sought. No further information is available.
This spontaneous report was received from a certified medical assistant concerning unspecified number of patients of unknown age and gender. No medical history or concurrent conditions were reported. On unknown dates,  between 02-AUG-2015 and 31-AUG-2015, the unspecified patients were vaccinated with PNEUMOVAX23 that was improperly stored (dose, strength, and route of administration were not provided). Co-suspect or concomitant therapies were not reported. The lot number reported for PNEUMOVAX23 was K006681 with expiration date on 21-OCT-2015. This is one of several reports from the same source. Additional information has been requested.
fever >103 & poss febrile sz w/in 48 hrs of vax